What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
- 1 January 2001
- journal article
- Published by Wiley in Haemophilia
- Vol. 7 (1) , 99-102
- https://doi.org/10.1111/j.1365-2516.2001.00471.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Primary prophylaxis in severe haemophilia should be started at an early age but can be individualizedBritish Journal of Haematology, 1999
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- The impact of prophylactic treatment on children with severe haemophiliaBritish Journal of Haematology, 1996
- Methods of haemophilia care delivery: regular prophylaxis versus episodic treatmentHaemophilia, 1995
- Results of secondary prophylaxis in children with severe hemophiliaAmerican Journal of Hematology, 1994
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994
- Implantable central venous catheter facilitates prophylactic treatment in children with haemophiliaActa Paediatrica, 1992
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992
- Prophylaxis with Factor Concentrates in Preventing Hemophilic ArthropathyJournal of Pediatric Hematology/Oncology, 1991
- Hemophilia A prophylaxis with factor VIII concentrate in a home‐treatment program: a controlled studyScandinavian Journal of Haematology, 1977